CD274 and cancer: At the same time researchers investigate approaches to determine the level of PD-L1 expression in malignant neoplasms to select patients subjected for therapy with PD-1/PD-L1 immune checkpoint inhibitors or PD-L1-targeted cytotoxic drugs.